omega-n-methylarginine has been researched along with Shock, Cardiogenic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brillante, DG; Howes, LG | 1 |
| Alexander, JH; Baran, DA; Buller, CE; Cantor, WJ; Cotter, G; Dzavík, V; Farkouh, ME; Gross, SS; Harrington, RA; Hathaway, D; Hazen, SL; Hochman, JS; Holmes, DR; Kleiman, NS; Ohman, EM; Panza, JA; Parrillo, JE; Prondzinsky, R; Ramanathan, K; Reynolds, HR; Stebbins, AL; Vered, Z; Webb, JG | 1 |
| Alon, D; Blatt, A; Cotter, G; Golik, A; Kaluski, E; Metzger, M; Michovitz, Y; Milovanov, O; Moshkovitz, Y; Salah, A; Vered, Z; Zaidenstein, R | 1 |
1 review(s) available for omega-n-methylarginine and Shock, Cardiogenic
| Article | Year |
|---|---|
Expert opinion on tilarginine in the treatment of shock.
Topics: Animals; Enzyme Inhibitors; Heart; Humans; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Shock, Cardiogenic; Shock, Septic; Sympathetic Nervous System | 2008 |
2 trial(s) available for omega-n-methylarginine and Shock, Cardiogenic
| Article | Year |
|---|---|
Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study.
Topics: Aged; Enzyme Inhibitors; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Myocardial Infarction; Nitric Oxide Synthase; omega-N-Methylarginine; Shock, Cardiogenic | 2007 |
L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock.
Topics: Aged; Blood Pressure; Enzyme Inhibitors; Female; Heart Rate; Humans; Male; omega-N-Methylarginine; Pulmonary Wedge Pressure; Shock, Cardiogenic; Treatment Outcome; Urine | 2000 |